Establishment Labs Executive and Leadership Team

Peter Caldini, the Chief Executive Officer at Establishment Labs, directs the global strategic vision for the company. Overseeing the commercialization of Femtech solutions, Caldini ensures that the organization maintains a competitive edge in the medical technology sector. This leadership role involves managing international market penetration and scaling operations to meet the rising demand for breast health innovations. By aligning corporate objectives with scientific advancements, Peter Caldini drives sustainable growth across diverse regions. The Chief Executive Officer collaborates with the board to optimize resource allocation and strengthen the company's market position. Through rigorous oversight of operational performance, Caldini secures long-term value for stakeholders while advancing the mission of improving women's health outcomes worldwide.

Juan Chacon Quiros, the Founder & Chief Executive Officer at Establishment Labs, architects the foundational scientific and engineering principles that define the company. Focusing on the development of breakthrough innovations like Mia Femtech, Quiros ensures that the product portfolio remains at the forefront of breast aesthetics and reconstruction. This leadership role involves fostering a culture of research and development, resulting in over 200 patent applications. By guiding the long-term technological roadmap, Juan Chacon Quiros directly impacts the company's ability to deliver minimally invasive experiences. The Founder & Chief Executive Officer maintains deep engagement with scientific studies to validate clinical outcomes. Ultimately, Quiros secures the company's reputation as a pioneer in medical technology through continuous investment in engineering excellence.

Sandra Harris, the Chief Financial Officer at Establishment Labs, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial reporting and investor relations, Harris ensures transparency and alignment with global regulatory standards. This leadership role involves optimizing the balance sheet to support the ongoing development of the Motiva Flora tissue expander and other core products. By directing financial planning and analysis, Sandra Harris provides the necessary resources for international expansion and research initiatives. The Chief Financial Officer collaborates with the executive team to mitigate financial risks while pursuing growth opportunities in the medical technology market. Through disciplined fiscal management, Harris supports the company's mission to provide advanced solutions for breast health and reconstruction on a global scale.

Roberto de Mezerville, the Chief Technology Officer at Establishment Labs, leads the engineering and technical development teams responsible for the company's proprietary medical devices. Overseeing the design and testing of the Motiva Flora tissue expander, de Mezerville ensures that all products meet rigorous safety and performance benchmarks. This leadership role involves managing the intellectual property portfolio and translating scientific research into scalable manufacturing processes. By driving innovation in breast reconstruction technology, Roberto de Mezerville directly impacts the clinical outcomes for patients worldwide. The Chief Technology Officer coordinates with the research department to integrate new materials and technologies into the existing product line. Through technical expertise, de Mezerville maintains the company's status as a leader in the Femtech industry.

Roberto Bolaños, the Project Management Office Chief of Staff at Establishment Labs, coordinates cross-functional initiatives to ensure the efficient execution of corporate projects. Overseeing the integration of departmental workflows, Bolaños ensures that product development timelines align with strategic business goals. This leadership role involves streamlining communication between engineering, clinical, and commercial teams to accelerate the delivery of new medical solutions. By managing complex project lifecycles, Roberto Bolaños directly impacts the company's operational agility and speed to market. The Project Management Office Chief of Staff monitors key performance indicators to identify bottlenecks and implement process improvements. Through meticulous planning and resource coordination, Bolaños supports the organization's ability to maintain a robust pipeline of breast health innovations across global markets.

Ross Mansbach, the Chief Compliance Officer & General Counsel at Establishment Labs, directs the legal and regulatory strategy for the company. Overseeing global compliance programs, Mansbach ensures that all operations adhere to international medical device standards and corporate governance requirements. This leadership role involves managing legal risks associated with intellectual property and clinical research publications. By providing counsel on regulatory filings, Ross Mansbach directly impacts the company's ability to enter new markets and maintain product certifications. The Chief Compliance Officer & General Counsel collaborates with the executive team to navigate complex legal landscapes in the medical technology sector. Through proactive risk management and legal oversight, Mansbach protects the company's assets and supports the ethical advancement of women's health solutions.